Page 27 of 27

PA27.8-17 | Renal Pathology II: Tubulointerstitial, Vascular & Neoplastic — PBL Case

CLINICAL SETTING

Kamala Devi, a 38-year-old mother of three from a farming village in Rajasthan, presents to a district hospital with acute severe left flank pain radiating to the groin, associated with nausea and vomiting. She has had two similar episodes in the past 3 years, each resolving spontaneously. She reports recurrent urinary tract infections (3 treated courses of antibiotics in the past year). Urine: turbid, foul-smelling. On direct questioning, she reports mild burning on urination and incomplete bladder emptying for months. She is not hypertensive and is not diabetic. There is no family history of kidney disease that she is aware of. Her 12-year-old son, Arjun, was recently noted at school to have consistently high blood pressure (145/94 mmHg on two readings), and has been sent for further evaluation along with his mother today. On examination of Kamala: mild distress, tender over the left costovertebral angle. Temp 38.4 °C, pulse 96, BP 132/84 mmHg. Abdomen: both flanks are visibly full, and bilateral firm flank masses are palpable — right larger than left, irregular and bosselated. Urine dipstick: protein 1+, blood 3+, leucocytes 3+, nitrite positive. Serum creatinine 1.8 mg/dL (elevated), BUN 42 mg/dL. Ultrasound abdomen: both kidneys grossly enlarged; the right kidney measures 22 cm and the left 18 cm; multiple bilateral cysts of varying sizes (0.5–8 cm) replace most of the parenchyma; no obvious solid mass; bilateral renal pelves dilated.

Trigger 1: Initial Workup — Mother and Son

Plain X-ray of Kamala's abdomen (KUB): bilateral large renal shadows; a radio-opaque calculus (1.8 cm) in the left renal pelvis. CT urogram confirms: autosomal dominant polycystic kidney disease (ADPKD) — bilateral massively enlarged kidneys with innumerable cysts; multiple hepatic cysts; the left-sided stone is a staghorn calculus partially filling the left renal pelvis. Culture of midstream urine: Escherichia coli > 10⁵ CFU/mL. Genetic counselling is arranged. Arjun (12 years) undergoes ultrasound: both his kidneys are normal in size but 2–3 small cortical cysts (<1 cm) are noted. BP 148/96 mmHg. Serum creatinine normal (0.6 mg/dL). His grandfather (Kamala's father, deceased at age 48) had died of a 'brain bleed', reportedly after complaining of the 'worst headache of his life'.

DISCUSSION POINTS

  • ADPKD is confirmed in Kamala. Describe the genetic basis of ADPKD (PKD1 and PKD2 genes, two-hit hypothesis, polycystin proteins, primary cilia dysfunction). Explain the inheritance pattern, the likelihood that Arjun has inherited the mutation, and the significance of his renal cysts at age 12.
  • Kamala's grandfather died of a subarachnoid haemorrhage — the classic extrarenal manifestation of ADPKD. Describe the extrarenal manifestations of ADPKD (intracranial berry aneurysms, hepatic cysts, mitral valve prolapse, colonic diverticuli) and explain why berry aneurysms are structurally weakened in this condition.
  • Kamala has a ureteric stone causing acute renal colic and recurrent UTIs. The KUB shows a radio-opaque stone. Classify renal stones by composition and radio-opacity (calcium oxalate, struvite, uric acid, cystine). Explain the pathogenesis of a staghorn calculus in the setting of recurrent UTI with urease-producing organisms. Which organisms are responsible, and why does alkaline urine promote struvite crystallisation?
  • Kamala's serum creatinine is 1.8 mg/dL. Her kidneys are massively enlarged but cyst-filled, representing progressive parenchymal replacement. Using the CKD staging framework, classify her current function. Describe the morphological changes of ADPKD kidneys (gross appearance, cyst histology, residual nephron architecture) and explain the mechanism by which cysts expand and compress remaining nephrons.
Click to reveal Trigger 2: Acute Deterioration and Urinary Infection (discuss previous trigger first!)

Trigger 2: Acute Deterioration and Urinary Infection

Kamala develops high fever (40.1 °C), rigors, and right loin pain four weeks after stone removal. Creatinine rises acutely to 3.4 mg/dL (baseline 1.8 mg/dL). CT shows right kidney enlargement with perinephric stranding and multiple small cortical abscesses. Urine culture: Klebsiella pneumoniae > 10⁵ CFU/mL (ESBL-positive). Blood cultures are also positive. The radiologist notes areas of cortical scarring in the right kidney with calyceal clubbing — consistent with chronic pyelonephritis/reflux nephropathy superimposed on ADPKD. Meanwhile Arjun's evaluation reveals elevated plasma renin activity and a narrowing of the right renal artery on Doppler — likely fibromuscular dysplasia causing renovascular hypertension.

DISCUSSION POINTS

  • Kamala has acute pyelonephritis superimposed on chronic pyelonephritis (CPN)/reflux nephropathy. Describe the pathological diagnostic triad of acute pyelonephritis on histology (gross and microscopic) and distinguish it from the gross and microscopic features of CPN/reflux nephropathy. What specific gross feature of CPN (coarse irregular scarring with calyceal clubbing) distinguishes it from hypertensive nephrosclerosis (diffuse finely granular surface)?
  • Arjun has fibromuscular dysplasia (FMD) causing renovascular hypertension. Compare FMD with atherosclerotic renal artery stenosis: age/sex predilection, site of stenosis (proximal vs distal, medial vs intimal), angiographic appearance (beads-on-a-string vs eccentric plaque), and the RAAS mechanism by which reduced perfusion pressure causes systemic hypertension.
  • The tubular compartment in acute pyelonephritis is directly involved. Describe how bacteraemia and direct tubular toxicity (from ESBL Klebsiella endotoxin) can cause acute tubular necrosis (ATN) superimposed on pyelonephritis — explain the pathological distinction between ATN (ischaemic: PCT necrosis, non-contiguous; nephrotoxic: PCT necrosis, contiguous) and tubulointerstitial nephritis from infection.
  • Kamala's AKI involves both obstructive and infective mechanisms. Describe the pathology of obstructive uropathy and hydronephrosis: (a) mechanism of tubular injury from back-pressure (tubular atrophy from compression), (b) gross morphological stages (pelvicaliectasis → parenchymal thinning → end-stage), and (c) which metabolic derangements develop fastest in bilateral complete obstruction.
Click to reveal Trigger 3: Tumour Detection and Family Screening (discuss previous trigger first!)

Trigger 3: Tumour Detection and Family Screening

Following recovery, Kamala undergoes surveillance CT as part of ADPKD monitoring. A new 3.2 cm solid enhancing mass is found in the right kidney — distinct from the cysts, with irregular margins and heterogeneous enhancement. Biopsy confirms: clear cell renal cell carcinoma (ccRCC), Fuhrman grade 2, VHL gene mutation confirmed on molecular testing. No lymph node or vascular involvement. Meanwhile, Kamala's 16-year-old niece (daughter of Kamala's sister) presents with a 4.5 cm renal mass discovered during evaluation for recurrent UTIs. Biopsy shows: a triphasic tumour with blastemal cells, stromal spindle cells, and poorly formed tubular structures (Wilms tumour/nephroblastoma). Finally, Kamala's 45-year-old brother is found to have bilateral thickened bladder walls with papillary lesions on cystoscopy. He has worked in a textile dyeing factory for 20 years. Biopsy shows high-grade papillary urothelial carcinoma.

DISCUSSION POINTS

  • Kamala's renal mass is ccRCC driven by VHL mutation. Describe the molecular pathogenesis of clear cell RCC: the VHL tumour suppressor gene, two-hit inactivation, loss of HIF-alpha regulation, and downstream effects on VEGF and PDGF (angiogenesis). Describe the characteristic gross (yellow-orange cut surface, haemorrhage, necrosis) and microscopic (sheets of cells with clear cytoplasm, thin-walled sinusoidal vessels) features of ccRCC.
  • Kamala's niece has Wilms tumour (nephroblastoma). Compare Wilms tumour with ccRCC across: age group, cellular origin (metanephric blastema vs renal tubular epithelium), genetics (WT1 mutations, Knudson two-hit), characteristic gross appearance (well-encapsulated, variegated), microscopic triphasic pattern (blastemal/stromal/epithelial components), and prognosis. Why is early surgical resection so important in Wilms tumour?
  • Kamala's brother has urothelial (transitional cell) carcinoma after 20 years of textile dye exposure. Identify the specific occupational carcinogens (aromatic amines — 2-naphthylamine, benzidine) and explain the mechanism of urothelial carcinogenesis. Describe the morphological spectrum of UC (low-grade papillary, high-grade invasive, carcinoma in situ), the field cancerisation concept, and why cystoscopy surveillance is required after treatment.
  • Thrombotic microangiopathy (TMA) is an important vascular renal complication. Compare HUS (typical, D+ in children — Shiga toxin E. coli O157:H7) and TTP (adults, ADAMTS13 deficiency) using: pathogenesis, age group, predominant organ involvement (kidney-predominant vs brain-predominant), blood film findings (schistocytes, thrombocytopenia), ADAMTS13 level, and the two consequences of microvascular fibrin-platelet thrombi in the kidney cortex (ATN and cortical ischaemia).

Group Task Assignments

Group 1: Tubulointerstitial Diseases and ATN

  • Construct a classification of tubulointerstitial nephritis by cause (ischaemic, toxic, infective, immune/allergic, metabolic, obstructive) with one representative disease and its key pathological feature for each category. Compare ischaemic ATN and nephrotoxic ATN: which tubular segment is affected, is the injury contiguous or non-contiguous, and what specific cast type appears in urine?
  • Describe the three clinical phases of ATN (initiation, oliguric/maintenance, recovery/polyuria) and the cellular mechanisms underlying each. Explain rhabdomyolysis-induced ATN: why does myoglobin cause tubular injury, and what are the gross and microscopic features in this specific aetiological context?

Competencies: PA27.8, PA27.9

Group 2: Pyelonephritis and Reflux Nephropathy

  • Compare acute pyelonephritis, chronic pyelonephritis (reflux nephropathy), and drug-induced allergic interstitial nephritis: aetiology, route of infection or trigger, histological diagnostic triad (APN), gross appearance, and distinguishing feature from hypertensive nephrosclerosis (CPN) and from glomerulonephritis.
  • Describe papillary necrosis as a unifying complication across tubulointerstitial diseases. List five conditions in which it occurs (NSAID use, sickle cell, diabetes, chronic analgesic abuse, obstructive uropathy — mnemonic NSAID + DIAB + OBSTRUCT) and explain the ischaemic mechanism targeting the inner medulla.

Competencies: PA27.10

Group 3: Vascular Diseases of the Kidney

  • Construct a table of vascular diseases of the kidney classified by vessel calibre: large (renal artery stenosis — atherosclerotic vs FMD), medium/small (benign nephrosclerosis — hyaline arteriolosclerosis; malignant nephrosclerosis — onion-skin hyperplasia + fibrinoid necrosis), and capillary/arteriolar (TMA — HUS, TTP). Include gross appearance, histological lesion, clinical consequence, and distinguishing lab feature for each.
  • Compare benign nephrosclerosis and malignant nephrosclerosis: describe the gross renal appearance (finely granular, symmetrically shrunken vs flea-bitten kidney with petechial haemorrhages), the histological arteriolar lesion in each, and the clinical threshold for malignant hypertension (diastolic BP > 120 mmHg with end-organ damage).

Competencies: PA27.11, PA27.15

Group 4: Cystic Diseases and Renal Stones

  • Compare ADPKD (PKD1/PKD2, autosomal dominant, adults) with ARPKD (PKHD1, autosomal recessive, perinatal/infantile) and with acquired cystic disease (CKD-related): inheritance, age at presentation, kidney size/appearance, extrarenal manifestations, ESRD timing, and distinguishing genetic test.
  • Classify renal stones by composition (calcium oxalate, calcium phosphate, struvite, uric acid, cystine): radio-opacity on KUB, urine pH at which each forms, associated metabolic or infective condition, and macroscopic appearance. Explain how struvite (staghorn) calculi form via the urease mechanism of specific bacteria.

Competencies: PA27.12, PA27.13

Group 5: Renal and Urothelial Tumours

  • Compare the three major renal tumours — clear cell RCC, Wilms tumour, and urothelial carcinoma of the renal pelvis — across: age group, cell of origin, genetic driver, gross appearance (colour, encapsulation, site), microscopic features, diagnostic IHC markers, pattern of spread, and signature paraneoplastic syndrome.
  • Describe the spectrum of urothelial carcinoma (papillary low-grade, papillary high-grade, flat carcinoma in situ) including the field cancerisation concept (why synchronous and metachronous tumours occur throughout the urothelium), the occupational carcinogens relevant to India (textile dyes, rubber, leather), and the role of cystoscopy in surveillance.

Competencies: PA27.14, PA27.16, PA27.17

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [PA27.8] Classify tubulointerstitial nephritis by cause (ischaemic, toxic, infective, immune/allergic, metabolic, obstructive). Describe the morphological features distinguishing each category and the predominant tubular segment affected by each type of injury.
  2. [PA27.9] Define and describe the pathogenesis of acute tubular necrosis. Compare ischaemic ATN (patchy, non-contiguous PCT necrosis) and nephrotoxic ATN (contiguous PCT necrosis). Describe the three clinical phases of ATN, the role of tubular back-leak and cast formation in oliguria, and the gross/microscopic morphological features.
  3. [PA27.10] Describe the aetiology, route of infection, pathological diagnostic triad, and complications of acute pyelonephritis. Describe chronic pyelonephritis/reflux nephropathy — its characteristic gross appearance (coarse irregular scarring + calyceal clubbing) and how it is distinguished from hypertensive nephrosclerosis. Describe papillary necrosis.
  4. [PA27.11] Classify vascular diseases of the kidney by vessel calibre. Describe benign nephrosclerosis (hyaline arteriolosclerosis, finely granular shrunken kidney) and malignant nephrosclerosis (fibrinoid necrosis, onion-skin hyperplasia, flea-bitten kidney). Describe renal artery stenosis as a cause of renovascular hypertension — compare atherosclerotic and fibromuscular dysplasia types.
  5. [PA27.12] Classify cystic kidney diseases. Describe ADPKD — genetics (PKD1/PKD2, two-hit, polycystin/cilia dysfunction), gross and microscopic morphology, extrarenal manifestations (berry aneurysm, hepatic cysts, MVP), ESRD risk, and comparison with ARPKD and acquired cystic disease.
  6. [PA27.13] Classify renal stones by composition and radio-opacity. Explain the pathogenesis of calcium oxalate, struvite (staghorn/infection), uric acid, and cystine stones — metabolic/infective triggers, urine pH dependence, and stone appearance. Describe obstructive uropathy and hydronephrosis — pathogenesis, morphological grades, and metabolic complications.
  7. [PA27.14] Classify renal tumours. Describe clear cell RCC — VHL two-hit pathogenesis, gross yellow-orange appearance, microscopic clear cytoplasm with sinusoidal vessels, pattern of spread (renal vein, IVC, cannonball metastases), paraneoplastic syndromes, and Fuhrman grading. Describe Wilms tumour — age, triphasic histology, WT1 genetics, and prognosis.
  8. [PA27.15] Describe thrombotic microangiopathy (TMA) as a pathological syndrome — endothelial injury, platelet-fibrin microthrombi, microangiopathic haemolytic anaemia with schistocytes. Compare HUS (Shiga toxin, children, kidney predominant, normal ADAMTS13) and TTP (ADAMTS13 deficiency, adults, neurological predominant). Describe the gross and microscopic renal changes in TMA.
  9. [PA27.16] Classify urothelial tumours — papillary (low/high grade) vs flat (CIS). Describe the occupational carcinogens (aromatic amines — 2-naphthylamine, benzidine) and the field cancerisation concept. Describe the pathological features (papillary fronds, invasion depth), staging (Ta, T1, T2, T3), and the clinical significance of painless haematuria in urothelial carcinoma.
  10. [PA27.17] Using a systematic reading framework (gross size/surface/cysts/mass → microscopic compartment → pattern → diagnosis), identify the gross and microscopic features of ADPKD kidneys, end-stage contracted kidneys, hydronephrotic kidneys, ccRCC, Wilms tumour, and chronic pyelonephritis in pathology specimens.